Skip to content
Dx

ICD-10-CM 2027 diagnosis code

E13Other specified diabetes mellitus

Not billable — use a more specific code

E13 is a header code, so it can't be reported by itself. Choose one of the 9 more specific codes beneath it.

Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS, effective October 1, 2026. Updated September 29, 2026. About our data

About E13

E13 is the ICD-10-CM diagnosis code for other specified diabetes mellitus. It belongs to block E08-E13 (diabetes mellitus) and chapter 4 (endocrine, nutritional and metabolic diseases). It is a header code, so it can't be reported by itself; one of its 9 subcodes must be used instead.

To report this condition, pick the subcode that matches the documentation: E13.0 (with hyperosmolarity), E13.1 (with ketoacidosis), E13.2 (with kidney complications), E13.3 (with ophthalmic complications), E13.4 (with neurological complications), E13.5 (with circulatory complications), E13.6 (with other specified complications), E13.8 (with unspecified complications) and 1 more.

Don't report E13 together with the conditions in its Excludes1 note: diabetes (mellitus) due to autoimmune process (E10.-), diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-), diabetes mellitus due to underlying condition (E08.-), drug or chemical induced diabetes mellitus (E09.-) and 3 more.

Use an additional code to identify control using: injectable non-insulin antidiabetic drugs (Z79.85), insulin (Z79.4), oral antidiabetic drugs (Z79.84) and oral hypoglycemic drugs (Z79.84).

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Specific codes under E13

Coding notes

IncludesFurther defines the content of the category
  • diabetes mellitus due to genetic defects of beta-cell function
  • diabetes mellitus due to genetic defects in insulin action
  • postpancreatectomy diabetes mellitus
  • postprocedural diabetes mellitus
  • secondary diabetes mellitus NEC
Excludes1Not coded here — never report together with this code
  • diabetes (mellitus) due to autoimmune process (E10.-)
  • diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
  • diabetes mellitus due to underlying condition (E08.-)
  • drug or chemical induced diabetes mellitus (E09.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • type 1 diabetes mellitus (E10.-)
Use additional codeAdd a secondary code to fully describe the condition
  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)

Notes that apply from higher levels

Instructions written at a parent level also apply to E13.

Broader instructions also apply from Chapter 4: Endocrine, nutritional and metabolic diseases.

Codes whose notes reference E13

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about E13

Is E13 billable?

No. E13 is a header code. Report one of its more specific subcodes instead.